AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 149 filers reported holding AMICUS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $338,790 | +16.5% | 27,861 | +20.3% | 0.01% | +27.3% |
| Q2 2023 | $290,852 | +21.3% | 23,157 | +7.1% | 0.01% | +22.2% |
| Q1 2023 | $239,788 | -15.1% | 21,622 | 0.0% | 0.01% | -18.2% |
| Q4 2022 | $282,383 | +25.5% | 21,622 | 0.0% | 0.01% | +10.0% |
| Q3 2022 | $225,000 | +1.8% | 21,622 | +4.9% | 0.01% | 0.0% |
| Q2 2022 | $221,000 | +13.3% | 20,619 | 0.0% | 0.01% | +42.9% |
| Q1 2022 | $195,000 | -18.1% | 20,619 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $238,000 | +20.8% | 20,619 | 0.0% | 0.01% | +14.3% |
| Q3 2021 | $197,000 | -1.0% | 20,619 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $199,000 | -7.0% | 20,619 | -4.8% | 0.01% | -12.5% |
| Q1 2021 | $214,000 | -57.2% | 21,667 | 0.0% | 0.01% | -65.2% |
| Q4 2020 | $500,000 | +63.4% | 21,667 | 0.0% | 0.02% | +64.3% |
| Q3 2020 | $306,000 | -9.2% | 21,667 | -3.1% | 0.01% | -12.5% |
| Q2 2020 | $337,000 | +62.8% | 22,362 | 0.0% | 0.02% | +33.3% |
| Q1 2020 | $207,000 | -5.0% | 22,362 | 0.0% | 0.01% | +20.0% |
| Q4 2019 | $218,000 | +27.5% | 22,362 | +5.1% | 0.01% | +25.0% |
| Q3 2019 | $171,000 | -30.8% | 21,279 | +7.5% | 0.01% | -27.3% |
| Q2 2019 | $247,000 | +16.0% | 19,803 | +26.5% | 0.01% | +10.0% |
| Q1 2019 | $213,000 | +42.0% | 15,657 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $150,000 | -20.6% | 15,657 | 0.0% | 0.01% | -11.1% |
| Q3 2018 | $189,000 | -22.9% | 15,657 | 0.0% | 0.01% | -25.0% |
| Q2 2018 | $245,000 | +4.3% | 15,657 | 0.0% | 0.01% | +9.1% |
| Q1 2018 | $235,000 | +16.3% | 15,657 | +11.4% | 0.01% | +22.2% |
| Q4 2017 | $202,000 | +18.1% | 14,057 | +14.3% | 0.01% | +12.5% |
| Q3 2017 | $171,000 | +37.9% | 12,303 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $124,000 | +40.9% | 12,303 | 0.0% | 0.01% | +50.0% |
| Q1 2017 | $88,000 | +44.3% | 12,303 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $61,000 | -33.0% | 12,303 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $91,000 | – | 12,303 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |